Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-22

Clinical Trial Update: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral octreotide capsules with injectable somatostatin analogs in acromegaly has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • injectable somatostatin analogs
  • oral octreotide capsules (octreotide)

Snippet

Sponsor: Chiasma, Inc. | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2022-04-22